BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28914199)

  • 1. Clinical Applications of Intravenous Immunoglobulins in Child Neurology.
    Gogou M; Papadopoulou-Alataki E; Spilioti M; Alataki S; Evangeliou A
    Curr Pharm Biotechnol; 2017 Nov; 18(8):628-637. PubMed ID: 28914199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
    Bembeeva RT; Zavadenko NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):83-93. PubMed ID: 26356621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
    Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
    Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy.
    Andzelm MM; Stredny CM
    Rheum Dis Clin North Am; 2023 Nov; 49(4):875-893. PubMed ID: 37821201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].
    Stangel M; Gold R
    Nervenarzt; 2004 Aug; 75(8):801-15. PubMed ID: 15224177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin use for neurologic diseases.
    Koski CL; Patterson JV
    J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current use of immunoglobulins in neurology].
    Cursiefen S; Mäurer M
    Nervenarzt; 2008 Sep; 79 Suppl 2():67-74; quiz 75-6. PubMed ID: 18679643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
    Korsak J
    Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
    Dalakas MC
    JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Early Intravenous Immunoglobulins in Halting Clinical and Radiographic Disease Progression in Rasmussen Encephalitis.
    Jaafar F; Obeid M; Beydoun A
    Pediatr Neurol; 2023 Aug; 145():30-35. PubMed ID: 37269621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravenous immunoglobulin in a cohort of children with drug-resistant epilepsy.
    Bello-Espinosa LE; Rajapakse T; Rho JM; Buchhalter J
    Pediatr Neurol; 2015 May; 52(5):509-16. PubMed ID: 25882078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rasmussen encephalitis in childhood.
    Topçu M; Turanli G; Aynaci FM; Yalnizoglu D; Saatçi I; Yigit A; Genç D; Söylemezoglu F; Bertan V; Akalin N
    Childs Nerv Syst; 1999 Aug; 15(8):395-402; discussion 403. PubMed ID: 10447611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins.
    Bien CG; Tiemeier H; Sassen R; Kuczaty S; Urbach H; von Lehe M; Becker AJ; Bast T; Herkenrath P; Karenfort M; Kruse B; Kurlemann G; Rona S; Schubert-Bast S; Vieker S; Vlaho S; Wilken B; Elger CE
    Epilepsia; 2013 Mar; 54(3):543-50. PubMed ID: 23216622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IVIG therapy in neurological disorders of childhood.
    Archelos JJ; Fazekas F
    J Neurol; 2006 Sep; 253 Suppl 5():V80-6. PubMed ID: 16998760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of immunoglobulins in the treatment of human epilepsy.
    Villani F; Avanzini G
    Neurol Sci; 2002 Apr; 23 Suppl 1():S33-7. PubMed ID: 12032585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy with intravenous immunoglobulins: complications and side-effects.
    Wittstock M; Benecke R; Zettl UK
    Eur Neurol; 2003; 50(3):172-5. PubMed ID: 14530624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin in the treatment of neurologic disorders.
    Živković S
    Acta Neurol Scand; 2016 Feb; 133(2):84-96. PubMed ID: 25997034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGIV in neurology--evidence and recommendations.
    Bril V; Allenby K; Midroni G; O'Connor PW; Vajsar J
    Can J Neurol Sci; 1999 May; 26(2):139-52. PubMed ID: 10352875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bickerstaff's brainstem encephalitis (BBE) in childhood: rapid resolution after intravenous immunoglobulins treatment.
    Pavone P; Le Pira A; Greco F; Vitaliti G; Smilari PL; Parano E; Falsaperla R
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2496-9. PubMed ID: 25268095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.